Hyderabad, May 14: Dr Reddy's Laboratories said on Friday that the first consignment of imported doses of Sputnik V vaccine that landed in India on May 1 received regulatory clearance from the Central Drugs Laboratory at Kasauli in Himachal Pradesh on May 13. As part of a limited pilot, the soft launch of the vaccine has started and the first dose was administered here today. Further consignments of imported doses are expected over the upcoming months, the company said in a statement.
Subsequently, the supply of the Sputnik V vaccine will start from Indian manufacturing partners. The imported doses of the vaccine are presently priced at Rs 948 plus 5 percent GST per dose with the possibility of a lower price point when local supply begins. Sputnik V COVID-19 Vaccine to Be Available in Market From Next Week, Says Government.
Here's the tweet:
First doses of #SputnikV administered in India. On the picture Deepak Sapra, Global Head of Custom Pharma Services at @drreddys Laboratories is getting a shot of Sputnik V in Hyderabad. ✌️ pic.twitter.com/iBbTeB2DmT
— Sputnik V (@sputnikvaccine) May 14, 2021
The company is working closely with its six manufacturing partners to fulfill regulatory requirements to ensure a smooth and timely supply. Dr Reddy's said it will work closely with stakeholders in the government and private sector to ensure the widest possible reach of the Sputnik V vaccine as part of the national inoculation effort.
This is a reaffirmation of the company's commitment to exploring every avenue in the fight against the Covid-19 pandemic. "With the rising cases in India, vaccination is the most effective tool in our battle against Covid-19. Contributing to the vaccination drive in India is our biggest priority right now to help Indians be healthy and safe," said G V Prasad, Co-Chairman and Managing Director.
(This is an unedited and auto-generated story from Syndicated News feed, LatestLY Staff may not have modified or edited the content body)